BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21296042)

  • 1. The effect of protease inhibition on the temporal stability of NT-proBNP in feline plasma at room temperature.
    Connolly DJ; Hezzell MJ; Fuentes VL; Chang YM; Swan R; Syme HM
    J Vet Cardiol; 2011 Mar; 13(1):13-9. PubMed ID: 21296042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of storage conditions on measurements of canine N-terminal pro-B-type natriuretic peptide.
    Hezzell MJ; Boswood A; Lötter N; Elliott J
    J Vet Cardiol; 2015 Mar; 17(1):34-41. PubMed ID: 25547663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sample handling on serum N-terminal proB-type natriuretic peptide concentration in normal dogs and dogs with heart disease.
    Collins SA; Patteson MW; Connolly DJ; Brodbelt DC; Torrance AG; Harris JD
    J Vet Cardiol; 2010 Apr; 12(1):41-8. PubMed ID: 20226751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease.
    Lalor SM; Connolly DJ; Elliott J; Syme HM
    J Vet Cardiol; 2009 May; 11 Suppl 1():S71-9. PubMed ID: 19398225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure.
    Schou M; Gustafsson F; Corell P; Kistorp CN; Kjaer A; Hildebrandt PR
    Am Heart J; 2007 Jul; 154(1):123-9. PubMed ID: 17584564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human cardiac hormone fragment N-terminal pro B-type natriuretic peptide is an intrinsically unstructured protein.
    Crimmins DL; Kao JL
    Arch Biochem Biophys; 2007 May; 461(2):242-6. PubMed ID: 17399679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of N-terminal pro B-type natriuretic peptide are associated with ST resolution failure after reperfusion for acute myocardial infarction.
    Lorgis L; Zeller M; Dentan G; Sicard P; Jolak M; L'Huillier I; Vincent-Martin M; Beer JC; Makki H; Gambert P; Cottin Y;
    QJM; 2007 Apr; 100(4):211-6. PubMed ID: 17434911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction.
    Downie PF; Talwar S; Squire IB; Davies JE; Barnett DB; Ng LL
    Clin Sci (Lond); 1999 Sep; 97(3):255-8. PubMed ID: 10464049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome.
    Khan SQ; Narayan H; Ng KH; Dhillon OS; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2009 Jun; 117(1):31-9. PubMed ID: 19170658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
    Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complimentary roles for N-terminal pro-B-type natriuretic peptide and spirometry to assess functional capacity in patients with complex mixed heart valve disease.
    Bissessor N; Wee YS; Jayasinghe R; Zeng I; Lowe B; Kolbe J; Ellyet K; Kerr A; White H; Stewart R
    Kardiol Pol; 2010 Jan; 68(1):1-10. PubMed ID: 20131183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of ANP and BNP to their N-terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus.
    Walther T; Stepan H; Pankow K; Gembardt F; Faber R; Schultheiss HP; Siems WE
    BJOG; 2004 May; 111(5):452-5. PubMed ID: 15104609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal B-natriuretic Peptide after coronary artery bypass graft surgery.
    Crescenzi G; Landoni G; Bignami E; Belloni I; Biselli C; Rosica C; Guarracino F; Marino G; Zangrillo A
    J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):147-50. PubMed ID: 19103499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
    Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
    J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis.
    Weber M; Hausen M; Arnold R; Nef H; Moellman H; Berkowitsch A; Elsaesser A; Brandt R; Mitrovic V; Hamm C
    Heart; 2006 Nov; 92(11):1639-44. PubMed ID: 16740919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe septic inflammation as a strong stimulus of myocardial NT-pro brain natriuretic peptide release.
    Wolff B; Haase D; Lazarus P; Machill K; Graf B; Lestin HG; Werner D
    Int J Cardiol; 2007 Nov; 122(2):131-6. PubMed ID: 17258824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population.
    Linssen GC; Bakker SJ; Voors AA; Gansevoort RT; Hillege HL; de Jong PE; van Veldhuisen DJ; Gans RO; de Zeeuw D
    Eur Heart J; 2010 Jan; 31(1):120-7. PubMed ID: 19854731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.